Every recall we track for MACLEODS PHARMA USA, INC — 34 in all — plus the complaints and injury reports the public filed about them.
Macleods Pharma recalls 150 mcg levothyroxine tablets due to subpotent drug levels. This may not provide proper thyroid hormone treatment. Consumers should contact pharmacy for guidance.
Macleods Pharma USA recalls 1000-count losartan/hydrochlorothiazide tablets (Rx only) due to plastic-like foreign substance. Consumers should check NDC 33342-050-44 and lot number BLK2304A.
Macleods Pharma USA recalls 50-count Levofloxacin 500mg tablets due to embossing mismatch with package inserts. This may cause confusion in identifying the correct medication.
Macleods Pharma recalls 1mg Eszopiclone tablets in 30-count bottles due to customer reports of missing tablets. Affected units may have 1-3 tablets missing from the bottle.
Macleods Pharma recalls 30-count, 90-count, and 1000-count Losartan Potassium & Hydrochlorothiazide Tablets due to AZIDO impurity levels exceeding safety limits. Consumers should not use these products.
Macleods Pharma recalls 30-count, 90-count, and 1000-count Losartan Potassium & Hydrochlorothiazide tablets due to AZIDO impurity levels exceeding safety limits. These prescription medications were manufactured in Plainsboro, NJ.
Macleods Pharma recalls 50mg/12.5mg Losartan Potassium & Hydrochlorothiazide tablets due to AZIDO impurity levels above acceptable limits. Rx-only bottles with specific NDC numbers and expiration dates are affected.
Macleods Pharma recalls 100mg Losartan Potassium Tablets due to AZIDO impurity levels above safety limits. Affected lots include BLI2107B (exp 06/2023) and others. Stop using and contact for return.
Macleods Pharma recalls 25mg Losartan Potassium Tablets due to unsafe AZIDO impurity levels. Affected lots from 2022 expire Nov 2022. Stop using immediately.
Macleods Pharma recalls 50mg Losartan Potassium Tablets due to AZIDO impurity levels exceeding safety limits. Affected lots include BLI2002A through BLI2104B. Contact for return instructions.
Macleods Pharma recalls 5mg Risedronate tablets due to failed content uniformity. Affected lots may not contain correct active ingredient levels.
Macleods Pharma USA recalls 10mg Olanzapine tablets due to cGMP deviations. Affected lots: BOB42029A, BOB4202B. Expired 09/2022. No specific remedy stated in recall.
Macleods Pharma USA recalls 10mg/20mg blood pressure tablets (NDC 33342-192-07) manufactured in India with cGMP deviations. Consumers should check lot numbers and contact the company for details.
Macleods Pharma recalls 10mg Rizatriptan Benzoate orally disintegrating tablets due to organic impurities found in lab tests. This prescription medication is not safe for use.
Macleods Pharma USA recalls 75mg Clopidogrel tablets due to foreign matter. Rx-only 500-count bottles with specific lot number and expiration date.
